Investor Update: ANGLE reports positive data from Parsortix FDA clinical study



[ad_1]

Key News from the Proactive Investors UK Newsroom:

ANGLE PLC (LON: AGL) has achieved positive results from its Parsortix FDA clinical study on metastatic bad cancer. The 400-subject clinical study will support an application for Clbad II regulatory approval for Parsortix in the United States.

Savannah Resources (LON: SAV) has increased the resources of its Mina do Barroso deposit in Portugal by 15% to nearly 290,000 tonnes of lithium oxide. The first reported and inferred resources for Aldeia overall have 25% higher grades than the other deposits previously defined at Mina do Barroso.

NetScientific Holding Company (LON: NSCI) ProAxsis has received encouraging preliminary data from the BRIDGE study, a major clinical trial funded by the British Lung Foundation and the European Respiratory Society. The results highlight ProAxsis' ability to monitor bacterial infections in real time in patients with lung diseases.

Bingo Group Rank has made a fully cash offer for its online gaming rival Stride Gaming (LON: STR). The offer of 151p per share values ​​Stride at £ 115m and represents a premium of 29% over closing last night.

Uber's initial figures since the IPO earlier this month were a loss of US $ 1 billion (£ 790 million), although revenues grew 20 percent to $ 3.1 billion. US. Quarterly figures were in line with expectations, although Uber shares remained well below their benchmark.

The Capital & Counties property group has received more disappointment from its first judicial development in London. After a review by its partner Transport For London, Capco has reduced by 10.5% the value of its stake in EPCL, the joint venture that is developing the project.

[ad_2]
Source link